A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have lost about 8.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that ICON plc, (NASDAQ: ICLR) a world-leading clinical research ...

Investors in ICON plc ICLR need to pay close attention to the stock based ... Currently, ICON is a Zacks Rank #4 (Sell) in the Medical Services industry that ranks in the Top 32% of our Zacks Industry ...

NEW YORK, NY / ACCESS Newswire / March 17, 2025 / Bernstein Liebhard LLP:Do you, or did you, own shares of ICON plc (NASDAQ:ICLR)?Did you ...

ICON plc, et al., No. 25-cv-00763 ... including shifting part of their clinical studies in-house and away from CROs like ICON. Despite these industry trends, ICON repeatedly represented that client ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical ... including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual ...

Mural Health & ICON partner to enhance participant and site experience in clinical trials: Berwyn, Pennsylvania Thursday, March 6, 2025, 17:00 Hrs [IST] Mural Health Technologies, ...

Cruz announces that investors with losses related to ICON plc ("ICON" or the "Company") (NASDAQ: ICLR) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR ...

Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds ICON plc (“ICON” or the ... cost reduction measures and other industry funding limitations.